A retrospective study evaluating efficacy and safety of compassionate use of tocilizumab in 13 patients with severe-to-critically ill COVID-19: analysis of well-responding cases and rapidly-worsening cases after tocilizumab administration
Shoji Hashimoto, Heita Kitajima, Tsuyoshi Arai, Yoshitaka Tamura, Takayuki Nagai, Hiroshi Morishita, Hiroto Matsuoka, Yuki Han, Seijiro Minamoto, Tomonori Hirashima, Tomoki Yamada, Yozo Kashiwa, Makoto Kameda, Seiji Yamaguchi, Kazuko Uno, Emi Nakayama, Tatsuo Shioda, Kazuyuki Yoshizaki, Sujin Kang, Tadamitsu Kishimoto, Toshio Tanaka
doi: https://doi.org/10.1101/2020.06.24.20134288
Shoji Hashimoto
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Heita Kitajima
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Tsuyoshi Arai
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Yoshitaka Tamura
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Takayuki Nagai
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Hiroshi Morishita
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Hiroto Matsuoka
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Yuki Han
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Seijiro Minamoto
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Tomonori Hirashima
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Tomoki Yamada
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Yozo Kashiwa
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Makoto Kameda
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Seiji Yamaguchi
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Kazuko Uno
2Louis Pasteur Center for Medical Research, Kyoto 606-8225, Japan
Emi Nakayama
3Department of Viral Infection, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
Tatsuo Shioda
3Department of Viral Infection, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
Kazuyuki Yoshizaki
4Institute of Scientific and Industry Research, Osaka University, Osaka 565-0871, Japan
Sujin Kang
5Laboratory of Immune Regulation, Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan
Tadamitsu Kishimoto
5Laboratory of Immune Regulation, Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan
Toshio Tanaka
1Osaka Prefecture Hospital Organization Osaka Habikino Medical Center, Osaka 583-3588, Japan
Article usage
Posted June 30, 2020.
A retrospective study evaluating efficacy and safety of compassionate use of tocilizumab in 13 patients with severe-to-critically ill COVID-19: analysis of well-responding cases and rapidly-worsening cases after tocilizumab administration
Shoji Hashimoto, Heita Kitajima, Tsuyoshi Arai, Yoshitaka Tamura, Takayuki Nagai, Hiroshi Morishita, Hiroto Matsuoka, Yuki Han, Seijiro Minamoto, Tomonori Hirashima, Tomoki Yamada, Yozo Kashiwa, Makoto Kameda, Seiji Yamaguchi, Kazuko Uno, Emi Nakayama, Tatsuo Shioda, Kazuyuki Yoshizaki, Sujin Kang, Tadamitsu Kishimoto, Toshio Tanaka
medRxiv 2020.06.24.20134288; doi: https://doi.org/10.1101/2020.06.24.20134288
A retrospective study evaluating efficacy and safety of compassionate use of tocilizumab in 13 patients with severe-to-critically ill COVID-19: analysis of well-responding cases and rapidly-worsening cases after tocilizumab administration
Shoji Hashimoto, Heita Kitajima, Tsuyoshi Arai, Yoshitaka Tamura, Takayuki Nagai, Hiroshi Morishita, Hiroto Matsuoka, Yuki Han, Seijiro Minamoto, Tomonori Hirashima, Tomoki Yamada, Yozo Kashiwa, Makoto Kameda, Seiji Yamaguchi, Kazuko Uno, Emi Nakayama, Tatsuo Shioda, Kazuyuki Yoshizaki, Sujin Kang, Tadamitsu Kishimoto, Toshio Tanaka
medRxiv 2020.06.24.20134288; doi: https://doi.org/10.1101/2020.06.24.20134288
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12762)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4597)
- Geriatric Medicine (420)
- Health Economics (730)
- Health Informatics (2931)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (470)
- Neurology (4372)
- Nursing (237)
- Nutrition (640)
- Oncology (2276)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6961)
- Radiology and Imaging (1531)
- Respiratory Medicine (915)
- Rheumatology (440)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)